US82003F1012 - Common Stock
SHARPS TECHNOLOGY INC
NASDAQ:STSS (5/1/2024, 4:20:01 PM)
After market: 0.26 +0.01 (+4.21%)0.2495
-0.02 (-6.87%)
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. The company is headquartered in Melville, New York. The company went IPO on 2022-04-14. The firm is designed and patented various safety syringes and is seeking commercialization by manufacturing and distributing its products. The firm provides Sharps Provensa, a line of smart safety syringes that offer solutions to global healthcare crises. Its Ultra-Low Waste syringes offer a solution to minimize vaccine waste while offering reliable needlestick protection. The Company’s products include Sharps Provensa PS-3ML, Sharps Provensa RS-1ML, Sharps Provensa PSU-0.3 ML, Sharps Provensa PS-1ML, and Sharps Provensa RTF PS Glass Prefillable Syringes. Its manufacturing facility is located over two hours from Budapest (over 160 kilometers from Budapest Airport). The Company’s wholly owned subsidiary is Safegard Medical, Inc.
SHARPS TECHNOLOGY INC
105 Maxess Road, Ste. 124
Melville NEW YORK
P: 15162464000
Employees: 3
Website: https://sharpstechnology.com/
Sharps Technology just reported results for the fourth quarter of 2023.
Sharps and Roncadelle are Joining Forces to Sell and Distribute their Securegard, SAFER, and Sologard Lines of Disposable Smart Safety Syringes and Expand...
Sharps and Roncadelle are Joining Forces to Supply Drug Delivery Systems to the International HealthCare Market Through an Expanded Network of North...
Agreement would result in Sharps and Roncadelle Joining Forces to Access Global Healthcare Organizations Through More Than 30 Sales Partners worldwide...
It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!
Here you can normally see the latest stock twits on STSS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: